Viral Destruction: Sponsored Q&A by Microthermics - - BioPharm International

ADVERTISEMENT

Viral Destruction: Sponsored Q&A by Microthermics


A range of industries—biotechnology, food and pharmaceuticals—must keep viral contamination out of their products. To do this effectively, a company needs a reliable, continuous process, and one that can be scaled to the company’s specific needs. To explore these topics, BioPharm International talked with John Miles, PhD, president and founder of MicroThermics Inc. This company specializes in small-scale solutions in high-temperature short-time (HTST) and ultra-high temperature (UHT) processes.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal
July 14, 2014
Shire and AbbVie Discuss Possible Deal
July 14, 2014
Author Guidelines

Click here